Predicta Biosciences
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 Main St, Cambridge, Massachusetts, 0...Website
www.predictabiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Predicta Biosciences
Predicta Biosciences develops breakthrough diagnostic platforms that combine single-cell genomics and liquid biopsy to deliver whole-genome insights from blood or bone marrow samples. Its flagship GenoPredicta suite enables non-invasive detection, characterization, and monitoring of hematologic malignancies transforming how clinicians track disease evolution and therapeutic response.Explore more
Predicta Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Predicta Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Predicta Biosciences
Check out if Predicta Biosciences is spiking on competitors!
Earning: See what the market has to say on Predicta Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once Predicta Biosciences has new funding data
Product Launch: Get notified when Predicta Biosciences launches new products
Click to see if Predicta Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Predicta Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Predicta Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Predicta Biosciences as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Predicta Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Predicta Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Predicta Biosciences.
Predicta Biosciences financials insights
Gather financial insights about Predicta Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$5.2M
2025
Series A
$23.4M
Predicta Biosciences Tech Stack
Predicta Biosciences News & Media
Predicta Biosciences Launches its First Molecular Diagnostic Product to Improve the Prognosis of Multiple Myeloma
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory Developed Test (LDT): GenoPredicta for bone marrow or blood. The test measures a spectrum of genomic alterations and can be used by ordering physicians to molecularly diagnose individuals who have or are at risk for multiple myeloma and inform therapeutic management. The test is conducted in a CLIA-ap
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Predicta Biosciences
Sign Up For FreeTo access detailed company insights
Predicta Biosciences develops breakthrough diagnostic platforms that combine single-cell genomics and liquid biopsy to deliver whole-genome insights from blood or bone marrow samples. Its flagship GenoPredicta suite enables non-invasive detection, characterization, and monitoring of hematologic malignancies transforming how clinicians track disease... Read More
